East Timor reported outbreaks of African swine fever last week, the first occurrence near its border with giant neighbor Indonesia of a virus that killed millions of pigs around Asia, the World Organization for Animal Health (OIE) said.
GlaxoSmithKline plc said on Monday its maintenance therapy for a form of ovarian cancer reduced the risk of disease progression or death by 38% in a late-stage study in cancer patients.
Bangladesh's drug regulatory authority on Sunday issued a ban on sales of popular heartburn drug ranitidine while it investigates a potential cancer-causing substance in the drug.
Novartis said on Sunday that Kisqali helped women with advanced breast cancer after menopause live longer, adding to data the Swiss company hopes will help convince doctors to choose its drug over Pfizer's blockbuster Ibrance.
A U.S. recommendation that consumers avoid vaping products containing the active ingredient in marijuana ahead of their legalization in Canada next month could be a blow to Canadian cannabis companies' hopes that the higher-margin products will help propel them to profitability.
CVS Health Corp said on Saturday it will discontinue sales the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products by the U.S. Food and Drug Administration.
People should stop using e-cigarettes, especially those with marijuana ingredient tetrahydrocannabinol (THC), U.S. public health officials recommended on Friday, as an investigation into illnesses and deaths related to vaping deepens.
Washington state Governor Jay Inslee on Friday urged state agencies to ban flavored and cannabis-derived vaping products, joining other states and the federal government in taking steps to reduce vaping amid a mysterious outbreak of deaths and illness.
GlaxoSmithKline and AstraZeneca both reported trial results that will likely make their competing drugs available to a wider group of ovarian cancer patients, possibly helping GSK catch its rival in a highly contested drug class.
Related Videos
Introducing the all-new Reuters News app
The new Reuters News app is here, redesigned from the ground up to fit your busy life.
